Contrast-enhanced ultrasonography for blood flow detection in hepatocellular carcinoma during lenvatinib therapy

ConclusionsThe viability of the HCC should be confirmed using CEUS when contrast-enhanced CT/MRI reveals lesion hypoenhancement during lenvatinib therapy.

Source: Journal of Medical Ultrasonics - March 30, 2022 Category: Radiology Source Type: research